Search clinical trials for: carbapenemase producing enterobacteriaceae

Total 499 results

Hospital Italiano de Buenos Aires

Not yet recruiting

Mortality of MBL-producing Enterobacteriaceae Bacteremias With the Combined Use of Ceftazidime-avibactam and Aztreonam vs. Other Active Antibiotics. A Multicenter Target Trial Emulation.

Bacteremia
University Hospital, Strasbourg, France

Recruiting

Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections (CarbaVim)

Carbapenemase-Producing Enterobacteriaceae

France
National University of Singapore
Pfizer; Biomerieux inc

Recruiting

EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics (RAPID)

Hospital-acquired Pneumonia | Ventilator Associated Pneumonia | Healthcare Associated Infection | Blood Stream Infections | Carbapenem-Resistant Enterobacteriaceae Infection

Taiwan, Malaysia, Thailand
Assistance Publique - Hôpitaux de Paris

Recruiting

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital (Prev-CPE)

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae

France
Hospital Italiano de Buenos Aires

Recruiting

Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC (KPC)

Carbapenemase-Producing Enterobacteriaceae

Argentina
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Cost-effectiveness of Controlling CPE (OPTIM-BHRe)

Carbapenemase-producing Enterobacteriaceae Infections
Maimónides Biomedical Research Institute of Córdoba
Mikrobiomik Healthcare Company S.L.

Recruiting

Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae (KAPEDIS)

Carbapenemase-producing Enterobacteriaceae Infection

Spain
Hospital Clinic of Barcelona
Fondo de Investigacion Sanitaria; Fundacion Clinic per a la Recerca Biomédica; Institut d'Investigacions Biomèdiques August Pi i Sunyer

Recruiting

Efficacy of a Probiotic or Fecal Microbiota Transplantation (FMT) on the Eradication of Rectal Multidrug-resistant Gram-negative Bacilli (MDR-GNB) Carriage (PROFTMDECOL) (PROFTMDECOL)

CARRIER STATE

Spain
Susy Hota
Sinai Health System, Ontario, Canada; University of Toronto, Ontario, Canada; The Toronto Invasive Bacterial Diseases Network, Ontario, Canada and other collaborators

Suspended

Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization (EFFECT-CPE)

Infection

Canada
Hospital Italiano de Buenos Aires

Unknown

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

Probiotics | Enterobacteriaceae Infections
Spanish Network for Research in Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (INCREMENT-SOT)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Bacterial Infections | Bacteremia | Infection | Organ Transplantation | Clinically Significant Bacteremia

Spain
Stephen Harbarth
European Commission

Unknown

Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy (R-GNOSIS WP3)

Intestinal Colonization With Multidrug-resistant Bacteria

Israel, Switzerland, France, Netherlands
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections

Carbapenem | Klebsiella Pneumonia
JESUS RODRIGUEZ BAÑO

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study (INCREMENT)

Clinically Significant Bacteremia

Spain
Region Skane
Lund University

Not yet recruiting

Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient

Multi-antibiotic Resistance
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Antibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Household Transmission Dynamics of Multidrug Resistant Enterobacterales (HOME)

Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
Assistance Publique - Hôpitaux de Paris

Recruiting

Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit (PITAGORE)

Sepsis | Septic Shock

France
University of Calgary
Medical University of South Carolina; University of Colorado, Denver; The Hospital... and other collaborators

Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection (HIKO-STEC)

Hemolytic-Uremic Syndrome | Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection

United States, Canada
University Hospital, Strasbourg, France

Recruiting

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg (CARBA)

Nfections, Enterobacterial

France
Fondation Hôpital Saint-Joseph

Recruiting

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient? (COPROBLSE2)

Enterobacteria Infections

France
University Hospital, Basel, Switzerland

Recruiting

Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (CPB-Epi Basel)

Infections With CPB

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Transmission of ESBL-producing Enterobacteriaceae

Hospital Acquired Infection

Switzerland
Western Galilee Hospital-Nahariya

Recruiting

Extended-spectrum β-lactamase -Producing Enterobacteriaceae (ESBL) Vertical Transmission in Women With Preterm Labor Versus Those in Term Pregnancy

Preterm Labor

Israel
Khon Kaen University

Recruiting

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Urinary Tract Infections | Kidney Transplantation | Klebsiella Infections | Escherichia Coli Infections | Anti-Infective Agents, Urinary

Thailand
Rambam Health Care Campus
Hadassah Medical Organization; Rabin Medical Center; The Chaim Sheba Medical...

Suspended

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections (SPICE-M)

Bacteremia | Enterobacteriaceae Infections | Beta Lactam Resistant Bacterial Infection

Israel
University Hospital, Strasbourg, France

Completed

Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections (CARBAPENEM)

Bacteremia

France
University Hospital, Grenoble
Becton, Dickinson and Company

Completed

Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management (CPO-VRE)

Multidrug-resistant Bacteria Screening

France
Assistance Publique - Hôpitaux de Paris

Completed

Temocillin in ESBL-Enterobacteriaceae Infections (TMO2016)

Infectious Disease

France
Hospital de Clinicas de Porto Alegre
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Terminated

Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems (ABOVE)

Bloodstream Infection | Carbapenem-Resistant Enterobacteriaceae Infection

Brazil
D'Or Institute for Research and Education

Enrolling by invitation

Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM

Bacterial Infections | Antibiotic Resistant Infection

Brazil
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
University Hospital, Basel, Switzerland
Gebert Rüf-Stiftung

Active, not recruiting

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Extended Spectrum Beta Lactamases (ESBL) E. Coli

Switzerland
Meridian Bioscience, Inc.

Active, not recruiting

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

Carbapenem-Resistant Enterobacteriaceae

United States, Canada
Kaleido Biosciences

Terminated

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms (VITORA)

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

United States
Centre Hospitalier Annecy Genevois
Hopital Foch; APHP; Sorbonne University; Hopitaux Civils de Colmar; CH Annecy Genevois

Completed

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae (TEMO-BLSE)

Urinary Tract Infection Bacterial
University of Calgary

Withdrawn

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Hemolytic-Uremic Syndrome

Canada
Fouad Madhi

Completed

Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children (PYELOBLSE)

Urinary Tract Infections

France
University Hospital of Cologne
Karolinska Institutet; University Hospital of North Norway; Goethe University; McGill... and other collaborators

Unknown

Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens (PILGRIM)

Patients at High Risk of Antibacterial Treatment Upon Admission

Germany
University Hospital, Angers

Unknown

Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).

ESBL-producing Enterobacteriaceae Infections
Universidad del Norte

Unknown

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

Urinary Tract Infections | Enterobacteriaceae Infections | Clinical Trial | Carbapenem | Klebsiella Pneumoniae Infection | Infection Due to ESBL Bacteria | Escherichia Coli Infection | Drug Resistance, Bacterial

Colombia
Nantes University Hospital

Completed

Prevalence of ESBL and CPE in French Nursing Homes (CARBEHPAD)

Enterobacteriaceae Infections

France
Centre Hospitalier Universitaire de Besancon

Unknown

Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM) (FOSF'HOM)

Urinary Tract Infections

France
Centre Hospitalier Universitaire de Besancon

Completed

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes. (R'EHPAD)

Drug Resistance, Bacterial

France
University of Pittsburgh

Completed

Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species

Infection | ESBL | Quinolone Resistance | Klebsiella Species

United States
University of Pittsburgh

Completed

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Enterobacteriaceae Infections

United States
University of Pittsburgh

Completed

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

Enterobacteriaceae Infections

United States
University Hospital, Grenoble
French National Network of Clinical Research in Infectious Diseases (RENARCI)

Unknown

Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae (TEMO-ESBL)

Urinary Tract Infections

France
Assistance Publique - Hôpitaux de Paris

Terminated

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli (FOXICOLI)

Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli

France
Central Hospital, Nancy, France

Terminated

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli (COLIFOX)

Urinary Tract Infections

France

Search clinical trials for: carbapenemase producing enterobacteriaceae

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations